PMID:22014014: Difference between revisions

From EcoliWiki
Jump to navigation Jump to search
New PMID: Page!
 
imported>Wikientrybot
change PMID template to TableEdit version
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{RightTOC}}
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.181206.E4f8733c4cb250-->
<!--
******************************************************************************************
*
*  ** PLEASE DON'T EDIT THIS TABLE DIRECTLY.  Use the edit table link under the table. **
*
****************************************************************************************** -->
{|  id="E4f8733c4cb250"  class=" tableEdit PMID_info_table" 


|-
!align=left  |Citation
||
'''Mahajan, A and Gally, D'''  (2011) Escherichia coli and the mucosal immune system. ''Expert Rev Clin Immunol'' '''7''':743-5
|-
!align=left  |Abstract
||
The meeting was held in the beautiful city of Ghent, Belgium, to bring together basic scientists and clinicians working on Escherichia coli and the mucosal immune system; in particular focusing on cellular interactions, immune modulation and vaccination strategies in humans and animals. The aim was to exchange knowledge on the pathogenicity of different types of E. coli and recent advances in the area of mucosal immunity. The meeting was timely given the recent outbreak in northern Germany of an emergent Shiga toxigenic E. coli strain that was associated with the deaths of over 45 people and caused hemolytic uremic syndrome in nearly 800 individuals according to the European Centre for Disease Prevention and Control.
|-
!align=left  |Links
||
[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=22014014 PubMed]
Online version:[http://dx.doi.org/10.1586/eci.11.68 10.1586/eci.11.68]
|-
!align=left  |Keywords
||
Animals; Belgium; Congresses as Topic; Escherichia coli Infections/immunology; Escherichia coli Infections/mortality; Escherichia coli Infections/prevention & control; Escherichia coli Vaccines/immunology; Escherichia coli Vaccines/therapeutic use; Germany/epidemiology; Hemolytic-Uremic Syndrome/immunology; Hemolytic-Uremic Syndrome/mortality; Hemolytic-Uremic Syndrome/prevention & control; Humans; Immunity, Mucosal; Shiga-Toxigenic Escherichia coli/immunology; Shiga-Toxigenic Escherichia coli/pathogenicity; Vaccination
|- class="tableEdit_footer"
|<span class="tableEdit_editLink plainlinks">[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=d41d8cd98f00b204e9800998ecf8427e.181206.E4f8733c4cb250&page=181206&pagename={{FULLPAGENAMEE}}&type=1&template=PMID_info_table edit table]</span> ||
|}
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.181206.E4f8733c4cb250-->
==Significance {{HelpIcon|Help:Literature}} ==
{{LitSignificance}}
== Useful Materials and Methods {{HelpIcon|Help:Literature}}==
{{LitMaterials}}
==Annotations {{HelpIcon|Help:Literature}}==
<protect><annotationlinks/></protect>
==EcoliWiki Links {{HelpIcon|Help:Literature}} ==
{{LitLinks}}
==See also==
==References==
{{RefHelp}}
<references/>

Latest revision as of 04:41, 15 September 2013

Citation

Mahajan, A and Gally, D (2011) Escherichia coli and the mucosal immune system. Expert Rev Clin Immunol 7:743-5

Abstract

The meeting was held in the beautiful city of Ghent, Belgium, to bring together basic scientists and clinicians working on Escherichia coli and the mucosal immune system; in particular focusing on cellular interactions, immune modulation and vaccination strategies in humans and animals. The aim was to exchange knowledge on the pathogenicity of different types of E. coli and recent advances in the area of mucosal immunity. The meeting was timely given the recent outbreak in northern Germany of an emergent Shiga toxigenic E. coli strain that was associated with the deaths of over 45 people and caused hemolytic uremic syndrome in nearly 800 individuals according to the European Centre for Disease Prevention and Control.

Links

PubMed Online version:10.1586/eci.11.68

Keywords

Animals; Belgium; Congresses as Topic; Escherichia coli Infections/immunology; Escherichia coli Infections/mortality; Escherichia coli Infections/prevention & control; Escherichia coli Vaccines/immunology; Escherichia coli Vaccines/therapeutic use; Germany/epidemiology; Hemolytic-Uremic Syndrome/immunology; Hemolytic-Uremic Syndrome/mortality; Hemolytic-Uremic Syndrome/prevention & control; Humans; Immunity, Mucosal; Shiga-Toxigenic Escherichia coli/immunology; Shiga-Toxigenic Escherichia coli/pathogenicity; Vaccination

Significance

You can help EcoliWiki by summarizing why this paper is useful

Useful Materials and Methods

You can help Ecoliwiki by describing the useful materials (strains, plasmids, antibodies, etc) described in this paper.

Annotations

<annotationlinks/>

EcoliWiki Links

Add links to pages that link here (e.g. gene, product, method pages)

See also

References

See Help:References for how to manage references in EcoliWiki.